Depression severity and effect of antidepressant medications [6]

JAMA

Volumn 303, Issue 16, 2010, Pages 1598-

  Glassman, Alexander H ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

CLINICAL PRACTICE; DEMOGRAPHY; DISEASE SEVERITY; HUMAN; LETTER; MAJOR DEPRESSION; POPULATION; PRIORITY JOURNAL; SAMPLE SIZE; DEPRESSION; HOSPITALIZATION; NOTE; PLACEBO EFFECT; META ANALYSIS (TOPIC); PATIENT;

ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS; PLACEBO EFFECT; SEVERITY OF ILLNESS INDEX; DEPRESSIVE DISORDER, MAJOR; META-ANALYSIS AS TOPIC; PATIENT DROPOUTS; SAMPLE SIZE;

EID: 77951659286     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.509     Document Type: Letter

References (4)

1. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47-53.
2. Brown WA, Johnson MF, Chen MG. Clinical features of depressed patients who do and do not improve with placebo. Psychiatry Res. 1992;41(3):203-214.
3. Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry. 2006;63(3):283-288. (Pubitemid 43345352)
4. Lesperance F, Frasure-Smith N, Koszycki D, et al; CREATE Investigators. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007;297(4): 367-379. (Pubitemid 46155798)